HRP20250042T1 - Polimorfi triazolnog antifungalnog spoja pc945 - Google Patents
Polimorfi triazolnog antifungalnog spoja pc945 Download PDFInfo
- Publication number
- HRP20250042T1 HRP20250042T1 HRP20250042TT HRP20250042T HRP20250042T1 HR P20250042 T1 HRP20250042 T1 HR P20250042T1 HR P20250042T T HRP20250042T T HR P20250042TT HR P20250042 T HRP20250042 T HR P20250042T HR P20250042 T1 HRP20250042 T1 HR P20250042T1
- Authority
- HR
- Croatia
- Prior art keywords
- crystalline form
- compound
- pharmaceutical composition
- spp
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
| PCT/GB2020/053107 WO2021111142A1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
| EP20824979.7A EP4069690B1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20250042T1 true HRP20250042T1 (hr) | 2025-03-14 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20250042TT HRP20250042T1 (hr) | 2019-12-06 | 2020-12-04 | Polimorfi triazolnog antifungalnog spoja pc945 |
Country Status (26)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016087880A1 (en) | 2014-12-05 | 2016-06-09 | Pulmocide Limited | Antimycotic compound |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院(广州呼吸中心) | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| AU2811689A (en) | 1987-11-20 | 1989-06-14 | Schering Corporation | Tri-and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| DK0736030T3 (da) | 1993-12-21 | 2001-10-29 | Schering Corp | Fungicide tetrahydrofuraner |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| ES2199291T3 (es) | 1995-06-02 | 2004-02-16 | Schering Corporation | Antifungicos de tetrahidrofurano. |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| PL212985B1 (pl) | 2001-04-03 | 2012-12-31 | Schering Corp | Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu |
| EP2141159A1 (en) * | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| WO2013036866A1 (en) | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| WO2016087880A1 (en) * | 2014-12-05 | 2016-06-09 | Pulmocide Limited | Antimycotic compound |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-03 IL IL293401A patent/IL293401B1/en unknown
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
-
2025
- 2025-10-15 US US19/359,464 patent/US20260060980A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220110726A (ko) | 2022-08-09 |
| CN114746415B (zh) | 2025-04-11 |
| PT4069690T (pt) | 2024-12-13 |
| LT4069690T (lt) | 2025-01-10 |
| CN114746415A (zh) | 2022-07-12 |
| JP2023505227A (ja) | 2023-02-08 |
| EP4509179A2 (en) | 2025-02-19 |
| HUE069799T2 (hu) | 2025-04-28 |
| CL2022001464A1 (es) | 2023-03-24 |
| IL293401B1 (en) | 2026-08-01 |
| MX2022006654A (es) | 2022-09-07 |
| US20260060980A1 (en) | 2026-03-05 |
| CO2022007808A2 (es) | 2022-06-30 |
| SMT202400514T1 (it) | 2025-01-14 |
| ES3000984T3 (es) | 2025-03-04 |
| SA522432879B1 (ar) | 2025-01-26 |
| EP4069690A1 (en) | 2022-10-12 |
| US12491182B2 (en) | 2025-12-09 |
| WO2021111142A1 (en) | 2021-06-10 |
| DK4069690T3 (da) | 2025-01-20 |
| PL4069690T3 (pl) | 2025-03-10 |
| BR112022006259A2 (pt) | 2022-06-21 |
| FI4069690T3 (fi) | 2025-01-21 |
| SI4069690T1 (sl) | 2025-03-31 |
| IL293401A (en) | 2022-07-01 |
| EP4069690B1 (en) | 2024-11-13 |
| AU2020397613A1 (en) | 2022-06-02 |
| CA3155829A1 (en) | 2021-06-10 |
| US20230028714A1 (en) | 2023-01-26 |
| GB201917867D0 (en) | 2020-01-22 |
| EP4509179A3 (en) | 2025-02-26 |
| RS66401B1 (sr) | 2025-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500779A5 (cg-RX-API-DMAC7.html) | ||
| FI4069690T3 (fi) | Triatsolisienilääkeyhdiste pc945:n polymorfeja | |
| JP2023505227A5 (cg-RX-API-DMAC7.html) | ||
| US6407129B1 (en) | Azole compounds, their production and their use | |
| EP1254659B1 (en) | Stable emulsion compositions | |
| JP2017536385A5 (cg-RX-API-DMAC7.html) | ||
| US7960416B2 (en) | Stable emulsion composition | |
| JP2017536371A5 (cg-RX-API-DMAC7.html) | ||
| JP5635075B2 (ja) | 抗真菌医薬組成物 | |
| NZ613167A (en) | Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds | |
| WO2003101392A2 (en) | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods | |
| CN107001343B (zh) | 抗真菌的化合物 | |
| ES2652670T3 (es) | Compuestos antifúngicos cristalinos | |
| US20050070551A1 (en) | Novel crystalline forms of conazoles and methods of making and using the same | |
| US20190000814A1 (en) | Antifungal Compounds | |
| AU2006241671A1 (en) | Stable emulsion composition | |
| US20090088443A1 (en) | Novel crystalline forms of conazoles and methods of making and using the same | |
| EP3060549B1 (en) | Novel antifungal oxodihydropyridinecarbohydrazide derivative | |
| US20080032994A1 (en) | Modified azole compounds as antifungal and antibacterial agents | |
| CN102659687B (zh) | 苯并咪唑胺类化合物及其制备方法和应用 | |
| WO2020005115A1 (ru) | 3,5-замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью | |
| US20130261301A1 (en) | Fungicide | |
| WO2005118577A1 (en) | Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods | |
| US6583164B1 (en) | Antimycotic drug composition | |
| BRPI9811679B1 (pt) | antifúngicos de 1-{4-[4-(4-{[4-fenil-4-(1 h-1,2,4-triazol-1-ilmetil)-1,3-dioxolan-2-il]metóxi}fenil)piperazin-1-il]fenil}imidazolidin-2-onas substituídas |